The U.S. FDA rejection of an MDMA-based drug from Lykos Therapeutics for PTSD in August 2024 has not dimmed hopes that other psychedelic-oriented therapies can gain approval, according to the CEO of ...

The fallout from the F.D.A.’s rejection of MDMA-assisted treatment for PTSD worries researchers and experts who fear other ...

A medicine based on MDMA – the active ingredient in recreational ... the results of a phase 2 trial of psilocybin – the active compound in magic mushrooms – which found that using it ...

A recent study has found that some autistic adults report lasting improvements in their mental health and social lives after ...

One of the biggest stories of last year was Lykos Therapeutics’ failure to get its MDMA candidate over the finish line for post-traumatic stress disorder (PTSD). But the biotech has reminded us ...

When Daphne Gordon first tried MDMA, everything changed. She had grown up steeped in the "just say no" messaging of the '90s, which taught that any amount of illegal drug use was a gamble with ...

Entering the field of psychedelic therapy requires patience, dedication to learning, and careful attention to legal and ...

Minutes joined U.S. veterans with PTSD as they attend a week-long psychedelic retreat in Mexico. Nearly a year later, most of ...

While psychedelics can lead to powerful experiences and new insights, they don’t directly "fix" us or create lasting change ...

Navy veteran Michael Giardina told Anderson Cooper he was able to "let go" of trauma from his childhood during a psychedelic ...

Supporting the decriminalization and study of psychedelics is a bold but necessary step forward. Now is the time to ...